Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Octreotide uptake in parathyroid adenoma.

Karaçavuş S, Kula M, Cihan Karaca Z, Unlühızarcı K, Tutuş A, Bayram F, Coban G.

Mol Imaging Radionucl Ther. 2012 Aug;21(2):77-9. doi: 10.4274/Mirt.4. Epub 2012 Aug 1.

2.

Tumor-induced osteomalacia: a case of diagnostic dilemma.

Robertson A, Mansberg R, Mansberg V, Van der Wall H, Hooper M.

Clin Nucl Med. 2007 Aug;32(8):631-4.

PMID:
17667438
3.

99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance.

Melloul M, Paz A, Koren R, Cytron S, Feinmesser R, Gal R.

Eur J Nucl Med. 2001 Feb;28(2):209-13.

PMID:
11303892
4.

[Diagnosis and surgical treatment of 48 cases of parathyroid adenoma and parathyroid carcinoma].

Yang ZQ, Zhu LW, Wang PZ.

Zhonghua Zhong Liu Za Zhi. 2006 Aug;28(8):625-7. Chinese.

PMID:
17236561
5.

Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.

Hofland LJ, Lamberts SW, van Hagen PM, Reubi JC, Schaeffer J, Waaijers M, van Koetsveld PM, Srinivasan A, Krenning EP, Breeman WA.

J Nucl Med. 2003 Aug;44(8):1315-21.

6.

Marked uptake of technetium-99m pertechnetate by parathyroid adenoma.

Kikuchi T, Watanobe H, Suda T, Tomiyama T, Masuda M.

Intern Med. 2001 Jun;40(6):506-9. Review.

7.

Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy.

Ugur O, Bozkurt MF, Hamaloglu E, Sokmensuer C, Etikan I, Ugur Y, Sayek I, Gulec SA.

Arch Surg. 2004 Nov;139(11):1175-9.

PMID:
15545562
8.

Pituitary incidentalomas detected with technetium-99m MIBI in patients with suspected parathyroid adenoma: preliminary results.

Tiktinsky E, Horne T, Friger M, Agranovich S, Lantsberg S.

World J Nucl Med. 2012 Jan;11(1):3-6. doi: 10.4103/1450-1147.98721.

9.

Right thyroid hemiagenesis with adenoma and hyperplasia of parathyroid glands -case report.

Oruci M, Ito Y, Buta M, Radisavljevic Z, Pupic G, Djurisic I, Dzodic R.

BMC Endocr Disord. 2012 Nov 13;12:29. doi: 10.1186/1472-6823-12-29.

10.
11.

Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.

De Jong M, Breeman WA, Bernard HF, Kooij PP, Slooter GD, Van Eijck CH, Kwekkeboom DJ, Valkema R, Mäcke HR, Krenning EP.

Q J Nucl Med. 1999 Dec;43(4):356-66.

PMID:
10731786
12.

A Case of Hyperparathyroidism due to a Large Intrathyroid Parathyroid Adenoma with Recurrent Episodes of Acute Pancreatitis.

Kageyama K, Ishigame N, Sugiyama A, Igawa A, Nishi T, Morohashi S, Kijima H, Daimon M.

Case Rep Endocrinol. 2017;2017:5376741. doi: 10.1155/2017/5376741. Epub 2017 Jul 26.

13.

Successful application of technetium-99m-labeled octreotide acetate scintigraphy in the detection of ectopic adrenocorticotropin-producing bronchial carcinoid lung tumor: a case report.

Esfahani AF, Chavoshi M, Noorani MH, Saghari M, Eftekhari M, Beiki D, Fallahi B, Assadi M.

J Med Case Rep. 2010 Oct 18;4:323. doi: 10.1186/1752-1947-4-323.

14.

Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy.

Rhee Y, Lee JD, Shin KH, Lee HC, Huh KB, Lim SK.

Clin Endocrinol (Oxf). 2001 Apr;54(4):551-4.

PMID:
11318793
15.

Uptake Difference by Somatostatin Receptors in a Patient with Neuroendocrine Tumor: 99mTc-Octreotide Uptake in the Lung without Uptake in Liver Lesions.

Pirayesh E, Amoui M, Assadi M.

Mol Imaging Radionucl Ther. 2015 Oct 5;24(3):128-31. doi: 10.4274/mirt.02996.

16.

Oesophageal conduit - a cause of diffuse mediastinal uptake on thyroid scintigraphy.

Sonoda LI, Balan KK.

Mol Imaging Radionucl Ther. 2013 Dec;22(3):112-5. doi: 10.4274/Mirt.147. Epub 2013 Dec 10.

17.

FGF23 Producing Mesenchymal Tumor.

Papierska L, Cwikła JB, Misiorowski W, Rabijewski M, Sikora K, Wanyura H.

Case Rep Endocrinol. 2014;2014:492789. doi: 10.1155/2014/492789. Epub 2014 Feb 3.

18.

The role of the three phase bone scintigraphy in the management of the patients with costochondral pain.

Koç ZP, Balcı TA, Ozyurtkan MO.

Mol Imaging Radionucl Ther. 2013 Dec;22(3):90-3. doi: 10.4274/Mirt.68077. Epub 2013 Dec 10.

19.

Visualization of Gallbladder with In-111 Octreotide Scan.

Özülker F, Özülker T, Tatoğlu MT, Küçüköz Uzun A.

Mol Imaging Radionucl Ther. 2015 Jun 5;24(2):87-9. doi: 10.4274/mirt.07108.

20.

Focal small-bowel localization of bone-imaging radiopharmaceutical in a child.

Franco A, Sanders KW.

Radiol Case Rep. 2015 Dec 7;7(4):701. doi: 10.2484/rcr.v7i4.701. eCollection 2012.

Supplemental Content

Support Center